SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001052918-21-000252
Filing Date
2021-07-01
Accepted
2021-07-01 12:26:21
Documents
10
Period of Report
2021-02-28

Document Format Files

Seq Description Document Type Size
1 AVRICORE HEALTH INC. avricore6kfeb2021.htm 6-K 11181
2 EXHIBIT 99.1 nr_ex99z1.htm EX-99.1 7536
3 EXHIBIT 99.2 nr_ex99z2.htm EX-99.2 11209
4 EXHIBIT 99.3 nr_ex99z3.htm EX-99.3 6313
5 EXHIBIT 99.4 nr_ex99z4.htm EX-99.4 9211
6 EXHIBIT 99.5 nr_ex99z5.htm EX-99.5 16231
7 IMAGE nrex99z1_1.jpg GRAPHIC 5101
8 IMAGE nrex99z2_1.jpg GRAPHIC 5101
9 IMAGE nrex99z3_1.jpg GRAPHIC 5178
10 IMAGE nrex99z5_1.jpg GRAPHIC 5178
  Complete submission text file 0001052918-21-000252.txt   91892
Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2
Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038
Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-51848 | Film No.: 211064910
SIC: 2834 Pharmaceutical Preparations